Verigene test sales fuel Q2 revenue growth for Nanosphere

08/7/2013 | GenomeWeb Daily News (free registration)

Northbrook, Ill.-based Nanosphere posted revenues of $1.9 million during the second quarter, up from $1.3 million in the same period last year. The molecular diagnostics company attributes this revenue growth to sales generated from its Verigene Gram-Positive Blood Culture Test.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX